Productive HIV-1 infection of normal human mammary epithelial cells. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Productive HIV-1 infection of normal human mammary epithelial cells.

AIDS. 1995 Aug;9(8):859-66. Unique Identifier : AIDSLINE MED/96014958
Toniolo A; Serra C; Conaldi PG; Basolo F; Falcone V; Dolei A; Institute of Medicine and Public Health, University of Pavia,; Varese, Italy.


Abstract: OBJECTIVE AND DESIGN: To determine the susceptibility of mammary epithelial cells (MEC) to HIV-1 as breastfeeding is an established route of HIV transmission, although the origin of virus in breastmilk is unclear. METHODS: Primary epithelial cell cultures were derived from the mammary glands of healthy donors; immortalized MEC lines were also used. HIV infection was followed by detection of infectious particle production, p24 antigen and viral sequences. RESULTS: Seven out of 11 primary MEC cultures and two out of three MEC lines were productively infected by HIV-1. Virus replication significantly reduced cell proliferation, although cell viability was only slightly affected. Cytopathic changes were not observed. MEC cultures expressed low levels of surface CD4, galactosylceramide and CD26, but essentially no human leukocyte antigen (HLA)-DR. Infection of HIV-permissive MEC cells was associated with the upregulation of surface HLA-DR and CD26. In contrast, the expression of CD4, tissue-specific markers, adhesion molecules and growth-factor receptors was downregulated. To a lesser extent, similar effects were also observed in non-permissive cells. Hormones (triiodothyronine plus beta-estradiol and prolactin) enhanced HIV replication, possibly through the stimulation of cellular DNA synthesis. CONCLUSIONS: We concluded that HIV-1 replication in ductal/alveolar MEC may be, in part, responsible for the presence of HIV-1 in milk; that hormones may stimulate virus replication; and that infection reduces the growth of epithelial cells. Although in vitro HIV is produced by MEC to a lesser extent than lymphoid cells, MEC-derived HIV might have selective advantages for the infection of mucosal epithelial cells during breastfeeding.
Keywords: Breast/CYTOLOGY/*VIROLOGY Breast Feeding Cell Line Disease Transmission, Vertical Epithelium/CYTOLOGY/VIROLOGY Female Hormones/PHARMACOLOGY Human HIV Infections/*ETIOLOGY/TRANSMISSION/VIROLOGY *HIV-1/PHYSIOLOGY/PATHOGENICITY Infant, Newborn Milk, Human/VIROLOGY Phenotype Pregnancy Support, Non-U.S. Gov't Virus Replication JOURNAL ARTICLEKWDbreast/cytology/KWDvirologybreastfeedingcelllinediseasetransmission,verticalepithelium/cytology/virologyfemalehormones/pharmacologyhumanhivinfections/KWDetiology/transmission/virologyKWDhiv-1/physiology/pathogenicityinfant,newbornmilk,human/virologyphenotypepregnancysupport,non-uKWDsKWDgov'tvirusreplicationjournalarticle
960228
M9621071

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .